- Home
- PDD vs MDT Comparison
PDD vs MDT Comparison
Compare PDD & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDD | MDT |
|---|---|---|
| Founded | 2015 | 1949 |
| Country | Ireland | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.9B | 131.9B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PDD | MDT |
|---|---|---|
| Price | $100.77 | $87.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 19 |
| Target Price | ★ $139.22 | $109.82 |
| AVG Volume (30 Days) | 5.7M | ★ 6.9M |
| Earning Date | 03-25-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 3.23% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $33,537,000,000.00 |
| Revenue This Year | $16.62 | $8.91 |
| Revenue Next Year | $12.21 | $6.71 |
| P/E Ratio | ★ $10.63 | $31.80 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $87.12 | $79.55 |
| 52 Week High | $139.41 | $106.33 |
Technical Indicators
Market Signals| Indicator | PDD | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 47.42 | 34.59 |
| Support Level | $99.19 | $85.41 |
| Resistance Level | $106.50 | $88.77 |
| Average True Range (ATR) | 3.08 | 1.61 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 44.22 | 33.42 |
Price Performance
Historical ComparisonAbout PDD PDD Holdings Inc.
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.